CT47A5
gene geneOn this page
Also known as CT47.5
Summary
CT47A5 (cancer/testis antigen family 47 member A5, HGNC:33286) is a protein-coding gene on chromosome Xq24, encoding Cancer/testis antigen 47A (Q5JQC4).
At a glance
- MANE Select transcript:
NM_001080142
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:33286 |
| Approved symbol | CT47A5 |
| Name | cancer/testis antigen family 47 member A5 |
| Location | Xq24 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | CT47.5 |
| Ensembl gene | ENSG00000237957 |
| Ensembl biotype | protein_coding |
| OMIM | 300784 |
| Entrez | 728072 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000439466
RefSeq mRNA: 1 — MANE Select: NM_001080142
NM_001080142
CCDS: CCDS35387
Canonical transcript exons
ENST00000439466 — 3 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001605494 | 120964305 | 120964460 |
| ENSE00001845922 | 120963026 | 120963166 |
| ENSE00003734826 | 120965348 | 120966348 |
Expression profiles
Bgee: expression breadth tissue_specific, 5 present calls, max score 71.67.
Top tissues by expression
133 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 71.67 | gold quality |
| right testis | UBERON:0004534 | 59.78 | gold quality |
| testis | UBERON:0000473 | 56.52 | gold quality |
| left testis | UBERON:0004533 | 55.87 | gold quality |
| colonic epithelium | UBERON:0000397 | 37.20 | gold quality |
| ventricular zone | UBERON:0003053 | 36.48 | gold quality |
| cortical plate | UBERON:0005343 | 36.47 | gold quality |
| bone marrow cell | CL:0002092 | 36.16 | gold quality |
| ganglionic eminence | UBERON:0004023 | 35.49 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 33.38 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 32.15 | gold quality |
| bone marrow | UBERON:0002371 | 31.74 | gold quality |
| muscle tissue | UBERON:0002385 | 31.06 | gold quality |
| sural nerve | UBERON:0015488 | 30.93 | gold quality |
| stromal cell of endometrium | CL:0002255 | 29.87 | gold quality |
| prefrontal cortex | UBERON:0000451 | 29.19 | gold quality |
| liver | UBERON:0002107 | 28.25 | gold quality |
| duodenum | UBERON:0002114 | 28.14 | gold quality |
| lymph node | UBERON:0000029 | 27.57 | gold quality |
| tonsil | UBERON:0002372 | 27.05 | gold quality |
| islet of Langerhans | UBERON:0000006 | 26.55 | gold quality |
| vermiform appendix | UBERON:0001154 | 26.42 | gold quality |
| gall bladder | UBERON:0002110 | 25.98 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 25.89 | gold quality |
| placenta | UBERON:0001987 | 25.81 | gold quality |
| blood | UBERON:0000178 | 25.74 | gold quality |
| urinary bladder | UBERON:0001255 | 25.72 | gold quality |
| leukocyte | CL:0000738 | 25.28 | gold quality |
| monocyte | CL:0000576 | 25.05 | gold quality |
| muscle of leg | UBERON:0001383 | 25.03 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 0.00 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
14 targeting CT47A5, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-5696 | 99.98 | 72.36 | 4487 |
| HSA-MIR-495-3P | 99.96 | 72.81 | 4197 |
| HSA-MIR-5688 | 99.96 | 73.23 | 4504 |
| HSA-MIR-6505-5P | 99.73 | 69.25 | 1595 |
| HSA-MIR-1290 | 99.59 | 69.90 | 2079 |
| HSA-MIR-190A-5P | 99.54 | 71.45 | 933 |
| HSA-MIR-190B-5P | 99.54 | 71.40 | 925 |
| HSA-MIR-12123 | 99.52 | 71.79 | 2990 |
| HSA-MIR-664A-3P | 99.22 | 71.08 | 2696 |
| HSA-MIR-653-3P | 98.31 | 67.71 | 1542 |
| HSA-MIR-6773-3P | 98.17 | 65.51 | 1213 |
| HSA-MIR-6839-5P | 96.74 | 68.29 | 1088 |
| HSA-MIR-378J | 96.44 | 66.20 | 1020 |
| HSA-MIR-6760-3P | 96.35 | 68.31 | 1001 |
Cross-species orthologs
0 orthologs
Paralogs (13): CT47A10 (ENSG00000224089), CT47A6 (ENSG00000226023), CT47A9 (ENSG00000226600), CT47A12 (ENSG00000226685), CT47A11 (ENSG00000226929), CT47A7 (ENSG00000228517), CT47A8 (ENSG00000230347), CT47A4 (ENSG00000230594), CT47A3 (ENSG00000236126), CT47A1 (ENSG00000236371), CT47B1 (ENSG00000236446), CT47A2 (ENSG00000242362), CT47C1 (ENSG00000277535)
Protein
Protein identifiers
Cancer/testis antigen 47A — Q5JQC4 (reviewed: Q5JQC4)
Alternative names: Cancer/testis antigen 47
All UniProt accessions (1): Q5JQC4
UniProt curated annotations — full annotation on UniProt →
Tissue specificity. Strongly expressed in testis, low expression in placenta, and very low expression in brain.
RefSeq proteins (1): NP_001073611* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR028930 | CT47 | Family |
Pfam: PF15623
UniProt features (14 total): compositionally biased region 9, region of interest 2, chain 1, sequence conflict 1, coiled-coil region 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q5JQC4-F1 | 53.93 | 0.00 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 4 (showing top):
chrXq24, MIR5696, MIR12123, MIR664A_3P
GO Biological Process (0):
GO Molecular Function (0):
GO Cellular Component (0):
Protein interactions and networks
STRING
350 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| CT47A5 | GPHRA | B7ZAQ6 | 952 |
| CT47A5 | TAF11L5 | A0A1W2PP81 | 654 |
| CT47A5 | TAF11L4 | A0A1W2PPE2 | 654 |
| CT47A5 | TAF11L3 | A0A1W2PRV1 | 654 |
| CT47A5 | TAF11L2 | A6NLC8 | 620 |
| CT47A5 | CTAG2 | O75638 | 616 |
| CT47A5 | CT45A1 | Q5HYN5 | 602 |
| CT47A5 | MAGEA1 | P43355 | 584 |
| CT47A5 | A0A1W2PRN6 | A0A1W2PRN6 | 544 |
| CT47A5 | CT55 | Q8WUE5 | 522 |
| CT47A5 | PRR20A | P86496 | 522 |
| CT47A5 | A0A1W2PQG5 | A0A1W2PQG5 | 520 |
| CT47A5 | SPANXA1 | Q9NS26 | 507 |
| CT47A5 | CSAG2 | Q9Y5P2 | 507 |
| CT47A5 | USP17L23 | D6RBM5 | 506 |
IntAct
3 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| CSAG2 | CAMK2D | psi-mi:“MI:0914”(association) | 0.350 |
| NXT2 | MYO1G | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (15): CT47A3 (Positive Genetic), CT47A2 (Positive Genetic), CT47A6 (Positive Genetic), CT47A5 (Positive Genetic), CT47A1 (Positive Genetic), CT47A7 (Positive Genetic), CT47A11 (Positive Genetic), CT47A4 (Positive Genetic), CT47A10 (Positive Genetic), CT47A12 (Positive Genetic), CT47A9 (Positive Genetic), CT47A8 (Positive Genetic), CT47A6 (Negative Genetic), CT47A3 (Negative Genetic), CT47A1 (Affinity Capture-MS)
ESM2 similar proteins: A0A0U1RQG5, A1L429, A6NDE8, A6NER3, A6NGK3, E1AZ71, O08664, O60829, O75459, O76087, P0C2W7, P0CL80, P0CL81, P0CL82, P0DSO3, P0DTW1, P52651, P62521, P86478, P86479, P86480, P86481, P86496, Q13066, Q13069, Q13070, Q17QW4, Q28181, Q2T9P9, Q32PA2, Q4V321, Q4V326, Q5JQC4, Q5U2Y8, Q62100, Q63803, Q64256, Q6NT46, Q6X7S9, Q7Z2X7
Diamond homologs: A0A0U1RQG5, P0C2W7, Q5JQC4
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
0 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 0 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
0 predictions. Top by Δscore:
AlphaMissense
0 scored. Top likely-pathogenic:
dbSNP variants (sampled 4 via entrez): RS1556343340 (X:120965475 G>C), RS1556343348 (X:120966345 T>C), RS2521588374 (X:120965860 C>T), RS2521588378 (X:120965957 C>T)
Disease associations
OMIM: gene MIM:300784 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.